Titan Biotech Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹48.83 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 13.59 per cent from ₹56.51 crore. This corresponds to a year-on-year *(YoY) growth of 38.84 per cent.
Operating Profit
Operating Profit stands at ₹9.71 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 10.34 per cent from ₹10.83 crore. This corresponds to a year-on-year *(YoY) growth of 112.47 per cent.
PBDT
PBDT stands at ₹11.75 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 6.00 per cent from ₹12.50 crore. This corresponds to a year-on-year *(YoY) growth of 90.75 per cent.
Profit Before Tax
Profit Before Tax stands at ₹10.45 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 6.95 per cent from ₹11.23 crore. This corresponds to a year-on-year *(YoY) growth of 96.43 per cent.
Net Profit
Net Profit stands at ₹6.73 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 21.10 per cent from ₹8.53 crore. This represents a 66.17 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Titan Biotech Ltd Earnings
- YOY
- QOQ
Titan Biotech Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Titan Biotech Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Titan Biotech Ltd Financial Reports
Titan Biotech Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Titan Biotech | 4.99% | -2.21% | -12.02% | -26.47% | 78.01% | 325.01% |
| Hester Bios | 0.97% | -0.42% | 14.59% | 54.68% | 39.79% | 22.90% |
| Ind-Swift Labs. | 3.47% | 4.41% | 37.04% | 52.71% | 139.13% | 87.91% |
| Windlas Biotech | 1.10% | 1.46% | 7.40% | 12.46% | 9.41% | -3.33% |
| Amrutanjan Healt | -2.12% | -0.02% | -1.19% | 4.12% | -18.29% | -24.40% |
| Jagsonpal Pharma | -0.15% | 1.43% | 15.86% | 22.99% | 23.38% | 1.38% |
| Fredun Pharma | -5.92% | -5.29% | 12.55% | 51.25% | 65.24% | 220.92% |
Company Info
Company Information
Chairman & Independent Directo : Rohit Jain
ED / MD / Promoter : Naresh Kumar Singla
ED / MD / Promoter : Suresh Chand Singla
Non-Exec & Non-Independent Dir : Manju Singla
Non-Exec & Non-Independent Dir : Supriya Singla
Independent Non Exe. Director : Dhairya Madan
Independent Non Exe. Director : Brijesh Kumar Singh
Independent Non Exe. Director : Abhishek Agarwal
WTD & Executive Director : Raja Singla
E D & Wholetime Director : Udit Singla
E D & Wholetime Director : Shivom Singla
Independent Non Exe. Director : Debendra Kumar Sabat
Company Sec. & Compli. Officer : CHARANJIT SINGH